TrianglePUBLICATIONS · 10561349
Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1999 Sep
- First author
- Chapman PB
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Chapman PB
- type
- Author
- name
- Einhorn LH
- type
- Author
- name
- Meyers ML
- type
- Author
- name
- Saxman S
- type
- Author
- name
- Destro AN
- type
- Author
- name
- Panageas KS
- type
- Author
- name
- Begg CB
- type
- Author
- name
- Agarwala SS
- type
- Author
- name
- Schuchter LM
- type
- Author
- name
- Ernstoff MS
- type
- Author
- name
- Houghton AN
- type
- Author
- name
- Kirkwood JM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Chapman PB
- type
- Author
- name
- Einhorn LH
- type
- Author
- name
- Meyers ML
- type
- Author
- name
- Saxman S
- type
- Author
- name
- Destro AN
- type
- Author
- name
- Panageas KS
- type
- Author
- name
- Begg CB
- type
- Author
- name
- Agarwala SS
- type
- Author
- name
- Schuchter LM
- type
- Author
- name
- Ernstoff MS
- type
- Author
- name
- Houghton AN
- type
- Author
- name
- Kirkwood JM
- type
- Author
- bibliography ids
- nci-bib-1b34b50aa655b4c2ab4c6064
- book metadata
- content sha256
- 220d878f1026c74084e230483926d8cf03a1f5d649849dfb83d23284d7450baa
- document type
- citation
- dois
- 10.1200/JCO.1999.17.9.2745
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:10561349
- immutable id
- pubmed:10561349@220d878f1026c74084e230483926d8cf03a1f5d649849dfb83d23284d7450baa
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 9
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2745-51
- volume
- 17
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 10561349
- provenance
- batch id
- 40703d4bdd5a70d2c67a
- provider
- NCBI PubMed ESummary
- record sha256
- fd3ce3fe984207c69c0454900522a60780af3af0c9fe5364c9044f09aa970687
- response sha256
- a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
- retrieved at
- 2026-09-09T23:45:35.800055+00:00
- publication date
- display
- 1999 Sep
- precision
- month
- year
- 1999
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.
Preserved source evidence · Not medical advice